EFFECT OF LIPIDS ON VASCULAR GRAFT HEALING

Summary

Principal Investigator: Linda M Graham
Abstract: DESCRIPTION (provided by applicant): Prosthetic grafts are used widely in vascular reconstructive surgery, but their long-term patency is limited by their thrombogenicity and the development of intimal hyperplasia. Oxidized LDL and lysophosphatidylcholine (lysoPC), a product of LDL oxidation, accumulate in grafts and alter cell function. The long-term goal of our research is to improve the patency of vascular grafts by promoting endothelial cell (EC) healing of graft surfaces. LysoPC inhibits EC migration in vitro, and hypercholesterolemia reduces EC migration into injured arteries and onto grafts. Old and lysoPC increase cellular production of reactive oxygen species, increase cell membrane fluidity, and open ion channels. These effects can inhibit EC migration. Specifically, lysoPC activates a canonical transient receptor potential (TRPC) ion channel, TRPC6, which opens TRPC5 through a unique TRPC activation cascade, leading to a prolonged rise in intracellular free calcium ion concentration ([Ca2+]i). Increased [Ca2+]i inhibits EC migration by activation of calpains that breakdown cytoskeletal proteins essential for migration. This proposal addresses the hypothesis that lipid oxidation products formed within synthetic vascular grafts inhibit their EC migration, in part through activation of TRPC6 and TRPC5 channels, and thereby limit endothelialization of grafts in vivo. The goals of this project are to identify mechanisms by which lipid oxidation products activate TRPC6 and TRPC5 channels and identify ways to counteract this. To accomplish these goals, the mechanism by which lipid oxidation products activate TRPC6, specifically the roles of Src kinases and phospholipase C-31, will be explored. In addition, and the mechanism by which TRPC6 activates TRPC5 will be studied, focusing on the role of intracellular calcium and myosin light chain kinase. The role of reactive oxygen species and changes in membrane fluidity in these actions will also be explored. Finally, the ability of an apoA-I mimetic or HDL, which we have shown to block the TRPC6-TRPC5 activation cascade in vitro, to improve EC migration in areas of arterial injury in mice and onto prosthetic grafts implanted in normal and hypercholesterolemic rabbits will be assessed. The proposed studies will investigate a mechanism by which lipid oxidation products limit EC healing of vascular injuries and synthetic vascular grafts. Studies will also address the ability of HDL to promote EC healing. These studies will lead to a better understanding of the role of lipids in the pathophysiology of graft failure, and provide impetus for development of TRPC6 channel inhibitors or agents that interrupt the TRPC6- TRPC5 activation cascade. These mechanism-based therapies will promote endothelial healing of angioplasty sites and prosthetic grafts to prolong their patency for the benefit of all people undergoing cardiovascular interventions. PUBLIC HEALTH RELEVANCE: The long-term goal of our research is improve the healing of bypass grafts or arteries after balloon angioplasty and stenting. We will investigate how oxidized lipids block the movement of endothelial cells (cells that normally line blood vessels) into an area of injury or onto a bypass graft. Specifically, we will study the role of certain ion channels (TRPC channels) that when eliminated abolish the inhibitory effect of high cholesterol in a mouse model. The results of these studies will provide direction in the development of treatments to promote endothelial cell healing after vascular interventions. For example, a TRPC6 inhibitor could increase endothelial cell migration and promote healing of arterial injuries and vascular grafts for the benefit all patients who require cardiovascular interventions.
Funding Period: 1999-12-01 - 2015-01-31
more information: NIH RePORT

Top Publications

  1. pmc Impaired graft healing due to hypercholesterolemia is prevented by dietary supplementation with alpha-tocopherol
    Keiko Miyazaki
    Department of Biomedical Engineering, Cleveland Clinic, Cleveland, Ohio, USA
    J Vasc Surg 48:986-93. 2008
  2. pmc Antioxidant therapy reverses impaired graft healing in hypercholesterolemic rabbits
    Michael A Rosenbaum
    Department of Biomedical Engineering, Cleveland Clinic, Cleveland, Ohio 44195, USA
    J Vasc Surg 51:184-93. 2010

Research Grants

  1. Sparstolonin B as an anti-atherogenic agent
    Daping Fan; Fiscal Year: 2013
  2. MECHANISMS OF PROSTHETIC ARTERIAL GRAFT FAILURE
    Frank W LoGerfo; Fiscal Year: 2013
  3. Caveolin-1 in Lipoprotein Metabolism and Atherosclerosis.
    Carlos Fernandez Hernando; Fiscal Year: 2013

Detail Information

Publications3

  1. pmc Impaired graft healing due to hypercholesterolemia is prevented by dietary supplementation with alpha-tocopherol
    Keiko Miyazaki
    Department of Biomedical Engineering, Cleveland Clinic, Cleveland, Ohio, USA
    J Vasc Surg 48:986-93. 2008
    ..The goal of this study was to determine the effect of elevated cholesterol on prosthetic graft healing and the ability of alpha-tocopherol to improve healing...
  2. pmc Antioxidant therapy reverses impaired graft healing in hypercholesterolemic rabbits
    Michael A Rosenbaum
    Department of Biomedical Engineering, Cleveland Clinic, Cleveland, Ohio 44195, USA
    J Vasc Surg 51:184-93. 2010
    ..Lipid accumulation and lipid oxidation are associated with decreased EC migration and intimal hyperplasia. The goal of this study was to assess the ability of antioxidants to improve graft healing in hypercholesterolemic animals...

Research Grants30

  1. Sparstolonin B as an anti-atherogenic agent
    Daping Fan; Fiscal Year: 2013
    ..The confirmation of the hypothesis will usher the development of SsnB as a new anti-atherogenic agent;it will also provide a pharmacological evidence for the causal role of TLR2 and TLR4 signaling in atherogenesis. ..
  2. MECHANISMS OF PROSTHETIC ARTERIAL GRAFT FAILURE
    Frank W LoGerfo; Fiscal Year: 2013
    ..It will greatly improve the treatment of atherosclerosis in the heart and circulation system. More general benefits will come for using biomaterials to deliver gene silencing for other purposes such as tissue repair. ..
  3. Caveolin-1 in Lipoprotein Metabolism and Atherosclerosis.
    Carlos Fernandez Hernando; Fiscal Year: 2013
    ....